Novartis Completes Sale of Animal-Health Division to Eli Lilly ZURICH—Novartis AG said Thursday it had completed a roughly $5.4 billion sale of its animal-health division to Eli Lilly & Co., part of the Swiss drug giant’s sweeping portfolio overhaul.